Zobrazeno 1 - 10
of 150
pro vyhledávání: '"Kimberly A, Hart"'
Autor:
Alexander M. Kaizer, Nathan I. Shapiro, Jessica Wild, Samuel M. Brown, B. Jessica Cwik, Kimberly W. Hart, Alan E. Jones, Michael S. Pulia, Wesley H. Self, Clay Smith, Stephanie A. Smith, Patrick C. Ng, B. Taylor Thompson, Todd W. Rice, Christopher J. Lindsell, Adit A. Ginde
Publikováno v:
International Journal of Infectious Diseases, Vol 128, Iss , Pp 223-229 (2023)
Objectives: Effective and widely available therapies are still needed for outpatients with COVID-19. We aimed to evaluate the efficacy and safety of lopinavir/ritonavir (LPV/r) for early treatment of non-hospitalized individuals diagnosed with COVID-
Externí odkaz:
https://doaj.org/article/a331a0a5b9994c778243d39b26885423
Autor:
Alexander M. Kaizer, Jessica Wild, Christopher J. Lindsell, Todd W. Rice, Wesley H. Self, Samuel Brown, B. Taylor Thompson, Kimberly W. Hart, Clay Smith, Michael S. Pulia, Nathan I. Shapiro, Adit A. Ginde
Publikováno v:
Trials, Vol 23, Iss 1, Pp 1-12 (2022)
Abstract Background Coronavirus disease 2019 (COVID-19) has a heterogeneous outcome in individuals from remaining asymptomatic to death. In a majority of cases, mild symptoms are present that do not require hospitalization and can be successfully tre
Externí odkaz:
https://doaj.org/article/1bf004d8143d460882da4454efee07ce
Autor:
Rachel M. Ancona, David Habib, Kiran A. Faryar, Andrew H. Ruffner, Kimberly W. Hart, Michael S. Lyons
Publikováno v:
Journal of the American College of Emergency Physicians Open, Vol 1, Iss 5, Pp 845-851 (2020)
Abstract Objectives Emergency departments (EDs) are called to implement public health and prevention initiatives, such as infectious disease screening. The perception that ED resources are insufficient is a primary barrier. Resource needs are general
Externí odkaz:
https://doaj.org/article/898bcc5b6146439b9c4062f5af415402
Autor:
Karla L. Otterpohl, Brook W. Busselman, Ishara Ratnayake, Ryan G. Hart, Kimberly R. Hart, Claire M. Evans, Carrie L. Phillips, Jordan R. Beach, Phil Ahrenkiel, Bruce A. Molitoris, Kameswaran Surendran, Indra Chandrasekar
Publikováno v:
JCI Insight, Vol 5, Iss 21 (2020)
Actin-associated nonmuscle myosin II (NM2) motor proteins play critical roles in a myriad of cellular functions, including endocytosis and organelle transport pathways. Cell type–specific expression and unique subcellular localization of the NM2 pr
Externí odkaz:
https://doaj.org/article/752c724f1621421da97c4604226a7520
Autor:
Rebecca A. Crow, Kimberly A. Hart, Michael P. McDermott, Rabi Tawil, William B. Martens, Barbara E. Herr, Elaine McColl, Jennifer Wilkinson, Janbernd Kirschner, Wendy M. King, Michele Eagle, Mary W. Brown, Deborah Hirtz, Hanns Lochmuller, Volker Straub, Emma Ciafaloni, Perry B. Shieh, Stefan Spinty, Anne-Marie Childs, Adnan Y. Manzur, Lucia Morandi, Russell J. Butterfield, Iain Horrocks, Helen Roper, Kevin M. Flanigan, Nancy L. Kuntz, Jean K. Mah, Leslie Morrison, Basil T. Darras, Maja von der Hagen, Ulrike Schara, Ekkehard Wilichowski, Tiziana Mongini, Craig M. McDonald, Giuseppe Vita, Richard J. Barohn, Richard S. Finkel, Matthew Wicklund, Hugh J. McMillan, Imelda Hughes, Elena Pegoraro, W. Bryan Burnette, James F. Howard, Mathula Thangarajh, Craig Campbell, Robert C. Griggs, Kate Bushby, Michela Guglieri
Publikováno v:
Trials, Vol 19, Iss 1, Pp 1-9 (2018)
Abstract Background Trials in rare diseases have many challenges, among which are the need to set up multiple sites in different countries to achieve recruitment targets and the divergent landscape of clinical trial regulations in those countries. Ov
Externí odkaz:
https://doaj.org/article/59fc2ba5f36543fab1efe37a189c7b3f
Autor:
Caitlin Turbyfill, Katherine Adams, Mark W. Tenforde, Nancy L. Murray, Manjusha Gaglani, Adit A. Ginde, Tresa McNeal, Shekhar Ghamande, David J. Douin, H. Keipp Talbot, Jonathan D. Casey, Nicholas M. Mohr, Anne Zepeski, Nathan I. Shapiro, Kevin W. Gibbs, D. Clark Files, David N. Hager, Arber Shehu, Matthew E. Prekker, Anne E. Frosch, Matthew C. Exline, Michelle N. Gong, Amira Mohamed, Nicholas J. Johnson, Vasisht Srinivasan, Jay S. Steingrub, Ithan D. Peltan, Samuel M. Brown, Emily T. Martin, Adam S. Lauring, Akram Khan, Laurence W. Busse, Caitlin C. ten Lohuis, Abhijit Duggal, Jennifer G. Wilson, Alexandra June Gordon, Nida Qadir, Steven Y. Chang, Christopher Mallow, Carolina Rivas, Jennie H. Kwon, Natasha Halasa, James D. Chappell, Carlos G. Grijalva, Todd W. Rice, William B. Stubblefield, Adrienne Baughman, Jillian P. Rhoads, Christopher J. Lindsell, Kimberly W. Hart, Meredith McMorrow, Diya Surie, Wesley H. Self, Manish M. Patel
Publikováno v:
Vaccine, vol 40, iss 48
BackgroundTest-negative design (TND) studies have produced validated estimates of vaccine effectiveness (VE) for influenza vaccine studies. However, syndrome-negative controls have been proposed for differentiating bias and true estimates in VE evalu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f3d4d9eebaaa287a091629da3368667
https://doi.org/10.1016/j.vaccine.2022.10.034
https://doi.org/10.1016/j.vaccine.2022.10.034
Autor:
Diya, Surie, Levi, Bonnell, Katherine, Adams, Manjusha, Gaglani, Adit A, Ginde, David J, Douin, H Keipp, Talbot, Jonathan D, Casey, Nicholas M, Mohr, Anne, Zepeski, Tresa, McNeal, Shekhar, Ghamande, Kevin W, Gibbs, D Clark, Files, David N, Hager, Arber, Shehu, Anne P, Frosch, Heidi L, Erickson, Michelle N, Gong, Amira, Mohamed, Nicholas J, Johnson, Vasisht, Srinivasan, Jay S, Steingrub, Ithan D, Peltan, Samuel M, Brown, Emily T, Martin, Akram, Khan, William S, Bender, Abhijit, Duggal, Jennifer G, Wilson, Nida, Qadir, Steven Y, Chang, Christopher, Mallow, Carolina, Rivas, Jennie H, Kwon, Matthew C, Exline, Adam S, Lauring, Nathan I, Shapiro, Natasha, Halasa, James D, Chappell, Carlos G, Grijalva, Todd W, Rice, William B, Stubblefield, Adrienne, Baughman, Kelsey N, Womack, Kimberly W, Hart, Sydney A, Swan, Yuwei, Zhu, Jennifer, DeCuir, Mark W, Tenforde, Manish M, Patel, Meredith L, McMorrow, Wesley H, Self, Carleigh, Samuels
Publikováno v:
MMWR. Morbidity and Mortality Weekly Report. 71:1327-1334
The SARS-CoV-2 Omicron variant (B.1.1.529 or BA.1) became predominant in the United States by late December 2021 (1). BA.1 has since been replaced by emerging lineages BA.2 (including BA.2.12.1) in March 2022, followed by BA.4 and BA.5, which have ac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::198a0fb85e6ad0bdec844161784e9cab
https://doi.org/10.15585/mmwr.mm7142a3
https://doi.org/10.15585/mmwr.mm7142a3
Autor:
Meagan, Stephenson, Samantha M, Olson, Wesley H, Self, Adit A, Ginde, Nicholas M, Mohr, Manjusha, Gaglani, Nathan I, Shapiro, Kevin W, Gibbs, David N, Hager, Matthew E, Prekker, Michelle N, Gong, Jay S, Steingrub, Ithan D, Peltan, Emily T, Martin, Raju, Reddy, Laurence W, Busse, Abhijit, Duggal, Jennifer G, Wilson, Nida, Qadir, Christopher, Mallow, Jennie H, Kwon, Matthew C, Exline, James D, Chappell, Adam S, Lauring, Adrienne, Baughman, Christopher J, Lindsell, Kimberly W, Hart, Nathaniel M, Lewis, Manish M, Patel, Mark W, Tenforde
Publikováno v:
Influenza and Other Respiratory Viruses. 16:1101-1111
During the COVID-19 pandemic, self-reported COVID-19 vaccination might facilitate rapid evaluations of vaccine effectiveness (VE) when source documentation (e.g., immunization information systems [IIS]) is not readily available. We evaluated the conc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69db2bb474b04e0b1783a450b9e935cf
https://doi.org/10.1111/irv.13023
https://doi.org/10.1111/irv.13023
Autor:
Diya Surie, Levi Bonnell, Jennifer DeCuir, Manjusha Gaglani, Tresa McNeal, Shekhar Ghamande, Jay S. Steingrub, Nathan Shapiro, Laurence W. Busse, Matthew E. Prekker, Ithan D. Peltan, Samuel M. Brown, David Hager, Harith Ali, Michelle Ng Gong, amira mohamed, Akram Khan, Jennifer Wilson, Nida Qadir, Steven Chang, Adit A. Ginde, David Huynh, Nicholas Mohr, Christopher Mallow, Emily T. Martin, Adam S. Lauring Lauring, Nicholas J. Johnson, Jonathan D. Casey, Kevin W. Gibbs, Jennie H. Kwon, Adrienne Baughman, James D. Chappell, Kimberly W. Hart, Carlos G. Grijalva, Jillian Rhoads, Sydney A. Swan, H. Keipp Talbot, Kelsey N. Womack, Yuwei Zhu, Mark W. Tenforde, Katherine Adams, Wesley H. Self, Meredith L. McMorrow
Publikováno v:
Vaccine.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12f424a47c9fe9246c48d3d6f51a3cb6
https://doi.org/10.1016/j.vaccine.2023.05.028
https://doi.org/10.1016/j.vaccine.2023.05.028
Autor:
Nathaniel M, Lewis, Wesley H, Self, Manjusha, Gaglani, Adit A, Ginde, David J, Douin, H, Keipp Talbot, Jonathan D, Casey, Nicholas M, Mohr, Anne, Zepeski, Shekhar A, Ghamande, Tresa A, McNeal, Nathan I, Shapiro, Kevin W, Gibbs, D Clark, Files, David N, Hager, Arber, Shehu, Matthew E, Prekker, Heidi L, Erickson, Michelle N, Gong, Amira, Mohamed, Nicholas J, Johnson, Vasisht, Srinivasan, Jay S, Steingrub, Ithan D, Peltan, Samuel M, Brown, Emily T, Martin, Arnold S, Monto, Akram, Khan, Laurence W, Busse, Caitlin C Ten, Lohuis, Abhijit, Duggal, Jennifer G, Wilson, Alexandra June, Gordon, Nida, Qadir, Steven Y, Chang, Christopher, Mallow, Carolina, Rivas, Hilary M, Babcock, Jennie H, Kwon, Matthew C, Exline, Adam S, Lauring, Natasha, Halasa, James D, Chappell, Carlos G, Grijalva, Todd W, Rice, Jillian P, Rhoads, Ian D, Jones, William B, Stubblefield, Adrienne, Baughman, Kelsey N, Womack, Christopher J, Lindsell, Kimberly W, Hart, Yuwei, Zhu, Katherine, Adams, Manish M, Patel, Mark W, Tenforde
Publikováno v:
Clinical Infectious Diseases. 75:S159-S166
Background . Adults in the United States (US) began receiving the adenovirus vector coronavirus disease 2019 (COVID-19) vaccine, Ad26.COV2.S (Johnson & Johnson [Janssen]), in February 2021. We evaluated Ad26.COV2.S vaccine effectiveness (VE) against
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d4efe6f52aace78e5793a53d83a0ad8
https://doi.org/10.1093/cid/ciac439
https://doi.org/10.1093/cid/ciac439